SCHEMBL20042774

SCHEMBL20042774

Cc1nc2c(c(N(C)C)n1)CNC2

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TUBB3 Q13509 5/20 0.34
ABCB1 P08183 3/20 0.34
HTR2C P28335 2/20 0.31
USP2 O75604 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17297899 0.75 HTR2A (0.33) HTR2C
SCHEMBL20042649 0.75 HTR2A (0.36) HTR2C
SCHEMBL28654615 0.72 HTR2A (0.35) HTR2C
SCHEMBL15859967 0.72
SCHEMBL20042661 0.72
Hydrochloric Acid SCHEMBL30321390 0.71 HTR2A (0.34) HTR2C
SCHEMBL22344966 0.71 HTR2C (0.32) HTR2C
SCHEMBL2806533 0.69 LRRK2 (0.38)
Hydrochloric Acid SCHEMBL29974030 0.69 HTR2C (0.34) HTR2C
SCHEMBL31614818 0.69 NPY5R (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4733303-A1 MUSCARINIC M4 RECEPTOR AGONIST AND USE THEREOF Haisco Pharmaceutical Group Co., Ltd. (CN) 2026-04-29 EP disclosed
WO-2024260386-A1 MUSCARINIC M4 RECEPTOR AGONIST AND USE THEREOF 西藏海思科制药有限公司 2024-12-26 WO disclosed
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed